论文部分内容阅读
目的:探讨雾化吸入喜炎平、布地奈德治疗毛细支气管炎的疗效及安全性。方法:将82例毛细支气管炎患儿按随机抽样法分为观察组和对照组,对照组给予静脉滴注利巴韦林、抗支原体药物及琥珀酸氢化可的松、氨茶碱治疗;观察组在对照组基础上雾化吸入喜炎平、布地奈德。结果:观察组和对照组患儿治疗1h后哮鸣音消失或减少的例数和呼吸困难、痰鸣音消失的时间差异有显著性。结论:雾化吸入喜炎平、布地奈德治疗毛细支气管炎能够迅速改善症状、缩短病程且用药安全有效。
Objective: To investigate the efficacy and safety of inhalation of Xiyanping and budesonide in the treatment of bronchiolitis. Methods: 82 children with bronchiolitis were randomly divided into observation group and control group. The control group was treated with intravenous ribavirin, anti-mycoplasma drug and hydrocortisone succinate, aminophylline. Groups were inhaled Xiyanping, budesonide on the basis of the control group. Results: There was a significant difference in the number of wheeze disappeared or decreased between the observation group and the control group after 1 hour of treatment, and the time when dyspnea and phlegm disappeared. Conclusion: The inhalation of Xiyanping, Budesonide in the treatment of bronchiolitis can quickly improve the symptoms, shorten the course and medication is safe and effective.